Literature DB >> 8410137

Intracerebral and subcutaneous xenografts of human SCLC in the nude rat: comparison of monoclonal antibody localization and tumor infiltrating lymphocytes.

J W Bulte1, K G Go, F Zuiderveen, T H The, L de Leij.   

Abstract

In the WAG/Rij nude rat, subcutaneous (s.c.) and intracerebral (i.c.) xenografts of the human SCLC cell line GLC-28 were evaluated for their growth behavior, in vivo monoclonal antibody binding and presence of tumor infiltrating lymphocytes. For the i.c. xenografts, two models of cerebral tumor growth were studied, one in the cerebral cortex and one in the lateral ventricle of the brain. In the s.c. and both i.c. xenografts models, in vivo localization of anti-carcinoma moab MOC-31 occurred within 4 hours after i.p. injection, with a maximal binding at 24 h after injection. A pronounced tumor infiltration of predominantly NK cells was observed for s.c. and intraventricular xenografts, but not for the GLC-28 tumors xenografted in the cerebral cortex. The presented nude rat/GLC-28 xenograft models may be used for the in vivo testing of experimental imaging techniques or alternative treatment strategies relevant to brain metastases of human SCLC.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8410137     DOI: 10.1007/bf01324829

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  22 in total

1.  CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival.

Authors:  J L Nugent; P A Bunn; M J Matthews; D C Ihde; M H Cohen; A Gazdar; J D Minna
Journal:  Cancer       Date:  1979-11       Impact factor: 6.860

2.  Growth of human lung tumor in the brain of the nude rat as a model to evaluate antitumor agent delivery across the blood-brain barrier.

Authors:  E A Neuwelt; E P Frenkel; A N D'Agostino; D N Carney; J D Minna; P A Barnett; C I McCormick
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

3.  Characterization of three new variant type cell lines derived from small cell carcinoma of the lung.

Authors:  L de Leij; P E Postmus; C H Buys; J D Elema; F Ramaekers; S Poppema; M Brouwer; A Y van der Veen; G Mesander; T H The
Journal:  Cancer Res       Date:  1985-12       Impact factor: 12.701

Review 4.  Small cell lung cancer: a problem of tumor heterogeneity.

Authors:  R G Sheehan
Journal:  Am J Med Sci       Date:  1986-10       Impact factor: 2.378

5.  Absence of thymus in a mouse mutant.

Authors:  E M Pantelouris
Journal:  Nature       Date:  1968-01-27       Impact factor: 49.962

6.  'Nude', a new hairless gene with pleiotropic effects in the mouse.

Authors:  S P Flanagan
Journal:  Genet Res       Date:  1966-12       Impact factor: 1.588

7.  Brain CT-scanning and neurological examination in small cell bronchogenic carcinoma.

Authors:  A G Pedersen; A Karle; G Boysen; K Højgaard; P Dombernowsky
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

8.  A glycolipid on the surface of mouse natural killer cells.

Authors:  M Kasai; M Iwamori; Y Nagai; K Okumura; T Tada
Journal:  Eur J Immunol       Date:  1980-03       Impact factor: 5.532

9.  The prognostic significance of histopathologic subtyping of small cell carcinoma of the lung according to the classification of the World Health Organization. A study of 375 consecutive patients.

Authors:  F R Hirsch; K Osterlind; H H Hansen
Journal:  Cancer       Date:  1983-12-01       Impact factor: 6.860

10.  Similarities in sequences and cellular expression between rat CD2 and CD4 antigens.

Authors:  A F Williams; A N Barclay; S J Clark; D J Paterson; A C Willis
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

View more
  1 in total

1.  Quantitative fluorine 18 deoxyglucose uptake by myocardial positron emission tomography in rats.

Authors:  Nobuhiro Handa; Yasuhiro Magata; Eiji Tadamura; Takahiro Mukai; Takeshi Nishina; Senri Miwa; Yutaka Sakakibara; Takuya Nomoto; Junji Konishi; Kazunobu Nishimura; Masashi Komeda
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.